Document is current
Any future updates will be listed below
-
Authors
Desai, Kinjal
Wanggou, Siyi
Luis, Erika
Whetstone, Heather
Yu, Chunying
Vanner, Robert J. https://orcid.org/0000-0003-1169-1778
Selvadurai, Hayden J.
Lee, Lilian
Vijay, Jinchu https://orcid.org/0000-0002-7311-475X
Jaramillo, Julia E.
Fan, Jerry
Guilhamon, Paul
Kushida, Michelle
Li, Xuejun
Stein, Gregory https://orcid.org/0000-0002-3588-8834
Kesari, Santosh
Simons, Benjamin D. https://orcid.org/0000-0002-3875-7071
Huang, Xi https://orcid.org/0000-0002-7177-7525
Dirks, Peter B. https://orcid.org/0000-0001-5718-6465
-
Funding
Funding for this research was provided by:
Gouvernement du Canada | Canadian Institutes of Health Research (FRN 133625)
- License Information
-
More Information
Article History
Received: 18 May 2023
Accepted: 22 November 2024
First Online: 4 February 2025
Competing interests
: G.S. is the CEO of Curtana Pharmaceuticals, and S.K. is on its board of directors. They generously provided us with CT-179 and were given the opportunity to read the manuscript prior to submission. They were not involved in the experimental design, nor in the interpretation of the results. The remaining authors declare no competing interests.
